CoImmune, Inc.
PrivateLast Round
Series A
Nov 10, 2020
Total Funding Raised
$56.1M
Company Overview
CoImmune, Inc. is a biotechnology company that specializes in the development of immuno-oncology therapies based on its two proprietary platform technologies, an autologous RNA-loaded dendritic cell technology and an allogeneic CAR-CIK technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoImmune, Inc. Comparables
Compare CoImmune, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diakonos Oncology | 82% | |
| CellxLife | 80% | |
| AiVita Biomedical | 74% | |
CoImmune, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 10, 2020 | ||||
| Corporate Funding | Feb 13, 2019 |
CoImmune, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series A |
| Korea Investment Partners | Series A |
| SCM Lifescience | Corporate Funding, Series A |
| Brain Asset Management Co.,Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2020
$45M round with SCM Lifescience and Genexine Inc.
- Feb 13, 2019
$11.1M raised from SCM Lifescience and Genexine Inc.
CoImmune, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CoImmune, Inc.'s valuation, stock price, and market status.